These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38050320)

  • 1. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon.
    Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J
    Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYLK and CALD1 as molecular targets in bladder cancer.
    Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
    Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.
    Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X
    Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of PAX6, TRPA1, BCL11B, MCOLN2, CUX1, EMX1 in colorectal cancer and osteosarcoma.
    Zhang J; Gao Q; Hou S; Chi X; Zheng M; Zhang Q; Shan H; Zhang X; Kang C
    Medicine (Baltimore); 2024 Feb; 103(5):e37056. PubMed ID: 38306561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.
    Zhang L; Liu B; Su J
    Medicine (Baltimore); 2023 Feb; 102(6):e32825. PubMed ID: 36820589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAV1 and KRT5 are potential targets for prostate cancer.
    Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
    Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RRP9 and DDX21 as new biomarkers of colorectal cancer.
    Chi X; Yang N; Liu Y
    Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis.
    Liu Y; Wu X; Wang G; Hu S; Zhang Y; Zhao S
    Medicine (Baltimore); 2019 Jan; 98(2):e13847. PubMed ID: 30633156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.
    Tan X; Chen M
    Tumour Biol; 2014 Dec; 35(12):12189-200. PubMed ID: 25179839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential crucial genes and key pathways in osteosarcoma.
    Liu J; Wu S; Xie X; Wang Z; Lei Q
    Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC and NCAPG2 as molecular targets of colorectal cancer and gastric cancer in nursing.
    Mi X; Shan H; Kang C; Zhang J; Hou S; Gao Y; Hao L; Gao X; Gao Q; Chi X; Zhang Q
    Medicine (Baltimore); 2024 May; 103(18):e38029. PubMed ID: 38701261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
    Fan H; Lu S; Wang S; Zhang S
    Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TOP2A and CDC6 in liver cancer.
    Jia W; Liu X; Zhang Z
    Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification.
    Wang H; Ma X; Li S; Su J; Fan B; Liu B; Ni X
    Aging (Albany NY); 2023 May; 15(11):4714-4733. PubMed ID: 37310408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
    Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
    Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
    Wang Q
    Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3D and CD247 are the molecular targets of septic shock.
    Yang Q; Feng Z; Ding D; Kang C
    Medicine (Baltimore); 2023 Jul; 102(29):e34295. PubMed ID: 37478215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for metastatic osteosarcoma biomarkers with a DNA microarray.
    Diao CY; Guo HB; Ouyang YR; Zhang HC; Liu LH; Bu J; Wang ZH; Xiao T
    Asian Pac J Cancer Prev; 2014; 15(4):1817-22. PubMed ID: 24641415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.